Diabetes patients on colchicine after PCI show lower in-stent restenosis rates

04/29/2013 | Healio

Data on 196 diabetes patients who underwent percutaneous coronary intervention with a bare-metal stent showed those who received colchicine had an in-stent restenosis rate of 16%, compared with 33% in the placebo group. Colchicine-treated patients also had lower rates of late lumen loss than those in the control group, researchers wrote in the Journal of the American College of Cardiology.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR